D-Wave Quantum: A 19% Sector Lift, Two Trimmed Targets and a Lawsuit Window That Closes in December

D-Wave Quantum shares jumped 19% on Friday, carried higher by the broader quantum-computing rally that followed IonQ's better-than-expected quarterly results and raised revenue guidance. The move had little to do with anything D-Wave itself reported. Instead, it reflected a sector-wide shift in sentiment — one that now faces its first real test when the company posts third-quarter 2026 results before the opening bell on November 10.

The announcement, dated October 27, also schedules a webcast for 8:00 a.m. ET that day. For investors weighing how much company-specific conviction sits behind the industry tailwind, that print is the next checkpoint.

Legal Cloud With a Narrow Window

On Monday, law firm Glancy Prongay Wolke & Rotter LLP publicized a securities class action against D-Wave. The complaint was filed on October 15, according to the firm, and covers shareholders who bought stock between February 26 and August 25, 2026. The allegations are claims, not court findings — a distinction that matters when sizing the risk. The deadline to seek lead-plaintiff status is December 15.

Analysts Stay Positive, but Cut Their Numbers

This week's target revisions show how cautiously even bullish observers are modeling the stock. On Monday, B. Riley Securities lowered its price target to $27 from $40 while keeping a buy rating. Two days later, Wedbush Securities trimmed its target to $30 from $37 and maintained an "Outperform" rating. Analyst Matt Bryson pointed to lower growth assumptions for the next two years and to developments including IonQ's capital raise.

The pattern is a familiar tension: a positive rating can travel alongside materially reduced expectations. Both firms remain constructive on D-Wave, provided the company can deliver operationally against those scaled-back forecasts.

A Faster Solver and a New Course Track

D-Wave reported its own technical progress on Wednesday, saying an upgraded version of its hybrid Stride solver found better solutions within 15 seconds in internal benchmark tests, compared with 120 seconds for the prior version. The company also launched a learning path featuring three courses on applied quantum optimization.

Separately, D-Wave published research from Florida Atlantic University on predicting lung cancer from limited data. The researchers used D-Wave annealing quantum computers. The reported prediction accuracy was preliminary and based on a dataset expanded with additional data, not on newly recruited patients.

What the November 10 Print Has to Prove

Cheaper sentiment for quantum computing can support the share price, but a durable re-rating needs technical gains to show up in the business. That link — better software, a viable commercial trajectory and careful handling of the legal overhang — is what the upcoming results will put on display. The sector backdrop helps the narrative; the company's own execution is what would make it hold.